Lexaria Bioscience Earnings Estimate

LEXX Stock  USD 2.13  0.02  0.93%   
By analyzing Lexaria Bioscience's earnings estimates, investors can diagnose different trends across Lexaria Bioscience's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Lexaria Bioscience Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Lexaria Bioscience is projected to generate -0.11 in earnings per share on the 31st of August 2024. Lexaria Bioscience earnings estimates module stress-tests analyst consensus about projected Lexaria Bioscience Corp EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Lexaria Bioscience, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Lexaria Bioscience Revenue Breakdown by Earning Segment

By analyzing Lexaria Bioscience's earnings estimates, investors can diagnose different trends across Lexaria Bioscience's analyst sentiment over time as well as compare current estimates against different timeframes. At this time, Lexaria Bioscience's Operating Profit Margin is fairly stable compared to the past year. Gross Profit Margin is likely to rise to 0.29 in 2024, whereas Gross Profit is likely to drop slightly above 212.9 K in 2024.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexaria Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Lexaria Bioscience Earnings per Share Projection vs Actual

About Lexaria Bioscience Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Lexaria Bioscience earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Lexaria Bioscience estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Lexaria Bioscience fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-41.2 M-39.1 M
Earnings Yield(0.02)(0.02)
Price Earnings Ratio(61.55)(58.47)
Price Earnings To Growth Ratio 0.74  0.78 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.